RGNX Trial readout: Friday, August 28, 2026
CompanyREGENXBIO Inc. (RGNX)
EventTrial readout
DateFriday, August 28, 2026
MarketUS listing
SourceCT.gov registry · confidence 50% · primary source ↗
Est. Completion: 2026-08. Status: RECRUITING. Title: AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)
Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.
Every date on this page is free — forever.
A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.